[Remote] Senior Computational Biologist (NYC) at Output Biosciences

New York, New York, United States

Apply Now

$150,000 – $250,000Compensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Artificial Intelligence, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

PythonComputational BiologyStructure PredictionMolecular DockingVirtual ScreeningProtein Language ModelsChemical Language ModelsMachine LearningData ScienceBiological ReasoningGenerative ModelsAI

Questions & Answers

Common questions about this position

What is the salary range for the Senior Computational Biologist position?

The salary range is $150K - $250K.

Is this role remote or based in an office?

This information is not specified in the job description.

What are the key qualifications for this role?

Candidates need a PhD in a biological field, strong Python programming skills, experience with computational biology tools like structure prediction and molecular docking, and experience with Protein or Chemical Language Models.

What is the company culture like at Output Biosciences?

The culture emphasizes heart with ownership and passion, excellence through high standards, and practicality with results-oriented thinking. They foster a collaborative, fast-paced startup environment.

What makes a strong candidate stand out for this position?

Strong candidates show a proactive approach to problem-solving, a mature mindset in ambiguity, excellent communication skills, and bonus experience with PyTorch, AWS, lab work, publications, or ML on biological data.

Output Biosciences

Develops preventative therapies for chronic diseases

About Output Biosciences

Output Biosciences focuses on developing preventative therapies aimed at extending human healthspan by addressing chronic diseases such as diabetes and heart disease. The company combines biotechnology with artificial intelligence to create therapies that can be discovered and manufactured more quickly and safely than traditional methods. This allows them to bring new treatments to market in just a few months, which is much faster than the usual drug development process. Their main clients include healthcare providers, pharmaceutical companies, and research institutions seeking effective solutions for chronic disease management. Output Biosciences differentiates itself by leveraging computational biology to streamline therapy development and commercialization, generating revenue through partnerships and licensing. The goal of Output Biosciences is to fundamentally change healthcare by preventing chronic diseases before they occur.

New York City, New YorkHeadquarters

2020Year Founded

$125KTotal Funding

PRE_SEEDCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1-10Employees

Risks

Increased competition from AI-driven biotech startups threatens market share.

Regulatory scrutiny on AI applications may delay approval processes.

Rapid technological advancements may render current methods obsolete without continuous innovation.

Differentiation

Output Biosciences integrates AI and computational biology for rapid therapy development.

The company focuses on preventative therapeutics to extend human healthspan.

Output Biosciences accelerates drug development timelines, bringing therapies to market in months.

Upsides

Growing interest in AI-driven drug discovery boosts investment and partnerships.

Rise of personalized medicine creates opportunities for tailored AI-integrated therapies.

FDA's acceptance of AI-driven drug development enables faster regulatory pathways.

Land your dream remote job 3x faster with AI

Try Jobo Free